News
$G1 Therapeutics(GTHX.US$ G1 Therapeutics And Deimos Biosciences Announced A Global Licensing Agreement (Excluding The Asia-pacific Region) For Lerociclib For Radioprotective Uses; G1 Is Expected To Receive 10% Of Deimos Biosciences' Shares In Addition To A 20% Sales-based Royalty
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
